Schedule 13D ownership disclosure

Mirum Pharmaceuticals Inc

Security class unavailable · CUSIP: 604749101

Event date: 2020-12-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-321142
Form type
SC 13D/A
Filer
Frazier Life Sciences IX, L.P.
CIK
CIK 1720320
Filed
Dec 18, 2020
Reporting period
Dec 17, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub